Label Image (Lbl500905619)
Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 50090-5619
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 50090-5619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Medroxyprogesterone 01)
This is a table that shows odds ratios and 95% confidence intervals for several studies on the risks associated with the use of DMPA (depot medroxyprogesterone acetate) for more than 12 months. The odds ratios shown are in logarithmic scale and a ratio greater than 1 indicates an increased risk for DMPA. The studies included in this analysis are from Lee et al. (1987), Paul et al. (1989), WHO (1991), Shapiro et al. (2000), and Li et al. (2012).*
Chemical Structure (Medroxyprogesterone 02)
Logo (Medroxyprogesterone 03)
Image (Medroxyprogesterone 04)
This appears to be a list of various methods of birth control, including statistics on different rates of pregnancy per 100 women per year depending on the method used. It also includes options such as injections, birth control pills, condoms, and more. However, some of the text is cut off, making it difficult to fully understand the content.*
Logo (Medroxyprogesterone 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
